Image_6_Immune Resolution Dilemma: Host Antimicrobial Factor S100A8/A9 Modulates Inflammatory Collateral Tissue Damage During Disseminated Fungal Peritonitis.tif
Intra-abdominal infection (peritonitis) is a leading cause of severe disease in surgical intensive care units, as over 70% of patients diagnosed with peritonitis develop septic shock. A critical role of the immune system is to return to homeostasis after combating infection. S100A8/A9 (calprotectin) is an antimicrobial and pro-inflammatory protein complex used as a biomarker for diagnosis of numerous inflammatory disorders. Here we describe the role of S100A8/A9 in inflammatory collateral tissue damage (ICTD). Using a mouse model of disseminated intra-abdominal candidiasis (IAC) in wild-type and S100A8/A9-deficient mice in the presence or absence of S100A9 inhibitor paquinimod, the role of S100A8/A9 during ICTD and fungal clearance were investigated. S100A8/A9-deficient mice developed less ICTD than wild-type mice. Restoration of S100A8/A9 in knockout mice by injection of recombinant protein resulted in increased ICTD and fungal clearance comparable to wild-type levels. Treatment with paquinimod abolished ICTD and S100A9-deficient mice showed increased survival compared to wild-type littermates. The data indicates that S100A8/A9 controls ICTD levels and antimicrobial activity during IAC and that targeting of S100A8/A9 could serve as promising adjunct therapy against this challenging disease.
History
References
- https://doi.org//10.2147/TCRM.S144262
- https://doi.org//10.1097/CCM.0000000000003342
- https://doi.org//10.3201/eid2302.152042
- https://doi.org//10.1016/j.medmal.2015.01.007
- https://doi.org//10.1159/000099009
- https://doi.org//10.1186/s13054-016-1458-3
- https://doi.org//10.2217/fmb.16.1
- https://doi.org//10.1016/j.mpsur.2008.01.004
- https://doi.org//10.2147/IDR.S152473
- https://doi.org//10.1002/bjs.4373
- https://doi.org//10.1038/nrmicro732
- https://doi.org//10.1146/annurev-physiol-022516-034348
- https://doi.org//10.1038/ni.3790
- https://doi.org//10.3389/fimmu.2018.01298
- https://doi.org//10.1038/nm1638
- https://doi.org//10.1016/j.celrep.2014.11.020
- https://doi.org//10.1172/JCI89867
- https://doi.org//10.1371/journal.pone.0203228
- https://doi.org//10.1172/JCI92450
- https://doi.org//10.1186/s12974-017-0989-0
- https://doi.org//10.1136/annrheumdis-2014-206517
- https://doi.org//10.3899/jrheum.160270
- https://doi.org//10.1167/iovs.17-23127
- https://doi.org//10.1074/jbc.R115.645085
- https://doi.org//10.1086/315810
- https://doi.org//10.1371/journal.ppat.1000639
- https://doi.org//10.1371/journal.pbio.1000097
- https://doi.org//10.1172/JCI62423
- https://doi.org//10.1128/mcb.23.7.2564-2576.2003
- https://doi.org//10.1128/mcb.23.3.1034-1043.2003
- https://doi.org//10.1128/mBio.00003-14
- https://doi.org//10.3389/fimmu.2012.00391
- https://doi.org//10.1203/PDR.0b013e3181f70eeb
- https://doi.org//10.1189/jlb.0213063
- https://doi.org//10.1371/journal.pone.0113840
- https://doi.org//10.15406/ghoa.2016.04.00107
- https://doi.org//10.1128/aac.19.1.179
- https://doi.org//10.1007/s00424-017-1958-2
- https://doi.org//10.3389/fphar.2017.00855
- https://doi.org//10.1016/j.bbrep.2016.03.009
- https://doi.org//10.1016/j.jim.2014.03.022
- https://doi.org//10.1016/s0016-5085(98)70646-8
- https://doi.org//10.1007/s12325-017-0622-8
- https://doi.org//10.1101/2020.03.30.017491
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity